Mostrando 6,841 - 6,860 Resultados de 9,628 Para Buscar '"Patente"', tiempo de consulta: 0.26s Limitar resultados
  1. 6841
    “…For example, cardiac actin was shown to be involved in pathogenesis of cardiac septum defects and smooth muscle actin in pathogenesis of aortic aneurysm in combination with patent ductus arteriosus (PDA). In the present study, we further searched for mutations in human α-cardiac actin (ACTC1) and smooth muscle α-actin (ACTA2) genes as a possible cause of atrial septum defect type II (ASDII) and PDA. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 6842
    por Stojanovski, Jadranka
    Publicado 2015
    “…RESULTS: The groups of biomedical and non-biomedical journals were similar in terms of originality (χ(2) = 2.183, P = 0.140), peer review process (χ(2) = 0.296, P = 0.586), patent/grant statement (χ(2) = 2.184, P = 0.141), and timeliness of publication (χ(2) = 0.369, P = 0.544). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 6843
  4. 6844
    “…METHODS: Medical records of patients undergoing laparoscopic SLN mapping for cervical cancer with either (99)Tc and patent blue dye (Group 1) or ICG (Group 2) from April 2008 until August 2012 were reviewed. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 6845
    “…A significant fraction of the new and updated databases are dedicated to the genetic basis of disease, primarily cancer, and various aspects of drug research, including resources for patented drugs, their side effects, withdrawn drugs, and potential drug targets. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 6846
    por Khanolkar, Uday B., Ephrem, Biju
    Publicado 2016
    “…Normal inflow and outflow with at least one of the three infrapopliteal vessels being patent is essential for adequate healing of chronic ulcers and prevention of major amputation.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 6847
    por Waheeb, Saad, Alshehri, Khalid
    Publicado 2016
    “…The risk factors that were assessed were intraventricular hemorrhage, patent ductus arteriosus (PDA), sepsis and hydrocephalus. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 6848
    por Qannam, Ahmed, Bello, Ibrahim O.
    Publicado 2016
    “…Most lesions (69%) occurred in patents aged 60–69 years. Although reactive lesions were generally the most common, the most common lesions were squamous cell carcinoma and fibroma. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 6849
    “…Primary blepharospasm patents had a broad range of cognitive deficits, with the most frequently affected domains being visuospatial function (30.9%) and language (30.9%), followed by memory (27.9%), orientation/attention (26.4%) and verbal fluency (22.0%). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 6850
    “…The patient remained hemodynamically stable; antegrade pyelography was done on the second postoperative day, there was distally patent ureter with no extravasation, neither contrast leak to renal vein, and was discharged home at third postoperative day. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 6851
    por Farzaneh, Shabnam, Zarghi, Afshin
    Publicado 2016
    “…This paper provides a general review of ER ligands published in international journals patented between 2013 and 2015. The broad physiological profile of estrogens has attracted the attention of many researchers to develop new estrogen ligands as therapeutic molecules for various clinical purposes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 6852
  13. 6853
    “…METHODS: The present study is a prospective cohort study aiming to compare the occurrence of no-reflow phenomenon, unstable angina, bleeding during intervention, and one month major adverse cardiac outcomes (recurrent MI, need for repeating surgical intervention, and mortality) between MI patents undergoing surgical intervention within the first 48 hours of or after 48 hours of thrombolytic therapy. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 6854
    por Eldarrat, Aziza, High, Alec, Kale, Girish
    Publicado 2017
    “…Scanning electron microscopy revealed structure of dentin sample with intertubular dentin matrix and distribution of patent dentinal tubules. CONCLUSION: This in vitro study indicated, through electrochemical impedance spectroscopy measurements, that electrical resistance of dentin was affected by the concentration of NaCl in electrolyte solution. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 6855
    “…After clinical and instrumental investigations, ES secondary to unrepaired patent ductus arteriosus with severe PAH was diagnosed. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 6856
    por Sarwar, Shahid, Khan, Anwaar A.
    Publicado 2017
    “…Treatment response was similar between treatment naïve 86.2% (119/138) and treatment experienced 79.4% (54/68) patents. (p value 0.19) SVR(12) was inferior in cirrhosis patients 75.4% (80/106) as compared to those with no cirrhosis 93% (93/100) (p value < 0.000). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 6857
    “…RESULTS: Time for performing the telescoped anastomosis was shorter (5.4±2.8 min versus 10.3±3.4 min, P<0.05). All grafts were patent and both types of anastomosis presented no bleeding. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 6858
    por Sharma, K., Babrowski, T., Milner, R.
    Publicado 2016
    “…ChEVAR was performed to preserve the IMA and flow to the HSK with a completion angiogram revealing patent renal arteries, IMA, and no evidence of an endoleak. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 6859
    “…The strain has been licensed with a patent numbered ZL 201210295819.6. The cellulase activity in the cultivation broth could reach up to 7.4 IU/mL at a non-optimized fermentation condition with the newly isolated T. virens ZY-01. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 6860
    “…Amongst the four agents used, EDTA and tetracycline consistently increased the diameter of tubules and percentage of patent tubules in both healthy and diseased teeth.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS